CompuGroup Medical SE KGaA Resultados de beneficios anteriores
Pasado controles de criterios 1/6
Los beneficios de CompuGroup Medical SE KGaA han disminuido a una tasa media anual de -4.5%, mientras que en la industria Healthcare Services los beneficios crecieron en un 2.2% anualmente. Los ingresos han ido creciendo a una tasa media de 12.5% al año. La rentabilidad financiera de CompuGroup Medical SE KGaA es de 7%, y sus márgenes netos son de 3.7%.
Información clave
-4.5%
Tasa de crecimiento de los beneficios
-6.2%
Tasa de crecimiento del BPA
| Crecimiento de la industria Healthcare Services | 7.9% |
| Tasa de crecimiento de los ingresos | 12.5% |
| Rentabilidad financiera | 7.0% |
| Margen neto | 3.7% |
| Próxima actualización de resultados | 08 May 2024 |
Actualizaciones de resultados anteriores recientes
Recent updates
CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Larger Dividend Than Last Year At €1.00
Apr 27
CompuGroup Medical SE KGaA's (ETR:COP) Upcoming Dividend Will Be Larger Than Last Year's
Apr 12We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Mar 20CompuGroup Medical SE & Co. KGaA (ETR:COP) Shares Could Be 49% Below Their Intrinsic Value Estimate
Feb 08Investors Interested In CompuGroup Medical SE & Co. KGaA's (ETR:COP) Earnings
Jan 25Is It Time To Consider Buying CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Jan 12The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Dec 28We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Dec 15Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Potentially Undervalued?
Oct 09CompuGroup Medical SE KGaA (ETR:COP) Could Be Struggling To Allocate Capital
Sep 22Do CompuGroup Medical SE KGaA's (ETR:COP) Earnings Warrant Your Attention?
Sep 07Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 33% Discount?
Aug 23Here's Why CompuGroup Medical SE KGaA (ETR:COP) Can Manage Its Debt Responsibly
Jul 13At €46.82, Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Worth Looking At Closely?
Jun 24CompuGroup Medical SE KGaA (ETR:COP) Is Reinvesting At Lower Rates Of Return
May 27CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11Is CompuGroup Medical SE & Co. KGaA (ETR:COP) Trading At A 32% Discount?
May 06We Think CompuGroup Medical SE KGaA (ETR:COP) Can Stay On Top Of Its Debt
Apr 06What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Mar 07Be Wary Of CompuGroup Medical SE KGaA (ETR:COP) And Its Returns On Capital
Feb 06An Intrinsic Calculation For CompuGroup Medical SE & Co. KGaA (ETR:COP) Suggests It's 28% Undervalued
Jan 21These 4 Measures Indicate That CompuGroup Medical SE KGaA (ETR:COP) Is Using Debt Reasonably Well
Jan 05Is Now An Opportune Moment To Examine CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Dec 06CompuGroup Medical SE KGaA (ETR:COP) May Have Issues Allocating Its Capital
Oct 27Are Investors Undervaluing CompuGroup Medical SE & Co. KGaA (ETR:COP) By 49%?
Oct 12At €39.20, Is It Time To Put CompuGroup Medical SE & Co. KGaA (ETR:COP) On Your Watch List?
Sep 04CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Aug 04Here's What's Concerning About CompuGroup Medical SE KGaA's (ETR:COP) Returns On Capital
Jul 16When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
May 31CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
May 11CompuGroup Medical SE KGaA (ETR:COP) Will Pay A Dividend Of €0.50
Apr 24CompuGroup Medical SE KGaA (ETR:COP) Has Announced A Dividend Of €0.50
Apr 10The Returns On Capital At CompuGroup Medical SE KGaA (ETR:COP) Don't Inspire Confidence
Mar 31What Does CompuGroup Medical SE & Co. KGaA's (ETR:COP) Share Price Indicate?
Feb 25CompuGroup Medical SE KGaA (ETR:COP) Has A Pretty Healthy Balance Sheet
Jan 26CompuGroup Medical SE KGaA (ETR:COP) Will Be Hoping To Turn Its Returns On Capital Around
Dec 21When Should You Buy CompuGroup Medical SE & Co. KGaA (ETR:COP)?
Nov 16Desglose de ingresos y gastosBeta
Cómo gana y gasta dinero CompuGroup Medical SE KGaA. Basado en los últimos beneficios reportados, en base a los últimos doce meses (LTM).
Historial de beneficios e ingresos
| Fecha | Ingresos | Beneficios | Gastos G+A | Gastos de I+D |
|---|---|---|---|---|
| 31 Dec 23 | 1,228 | 46 | 24 | 0 |
| 30 Sep 23 | 1,247 | 76 | 26 | 0 |
| 30 Jun 23 | 1,249 | 89 | 25 | 0 |
| 31 Mar 23 | 1,214 | 70 | 25 | 0 |
| 31 Dec 22 | 1,175 | 73 | 22 | 0 |
| 30 Sep 22 | 1,127 | 72 | 16 | 0 |
| 30 Jun 22 | 1,116 | 71 | 17 | 0 |
| 31 Mar 22 | 1,088 | 76 | 18 | 0 |
| 31 Dec 21 | 1,063 | 69 | 18 | 0 |
| 30 Sep 21 | 1,021 | 66 | 14 | 0 |
| 30 Jun 21 | 975 | 72 | 14 | 0 |
| 31 Mar 21 | 915 | 71 | 13 | 0 |
| 31 Dec 20 | 869 | 73 | 13 | 0 |
| 30 Sep 20 | 833 | 77 | 11 | 0 |
| 30 Jun 20 | 779 | 60 | 11 | 0 |
| 31 Mar 20 | 781 | 58 | 11 | 0 |
| 31 Dec 19 | 770 | 66 | 11 | 0 |
| 30 Sep 19 | 757 | 87 | 20 | 0 |
| 30 Jun 19 | 742 | 86 | 19 | 0 |
| 31 Mar 19 | 747 | 97 | 19 | 0 |
| 31 Dec 18 | 736 | 96 | 19 | 0 |
| 30 Sep 18 | 707 | 65 | 22 | 0 |
| 30 Jun 18 | 678 | 52 | 21 | 0 |
| 31 Mar 18 | 624 | 39 | 21 | 0 |
| 31 Dec 17 | 599 | 31 | 21 | 0 |
| 30 Sep 17 | 586 | 41 | 16 | 0 |
| 30 Jun 17 | 583 | 46 | 16 | 0 |
| 31 Mar 17 | 578 | 47 | 16 | 0 |
| 31 Dec 16 | 571 | 45 | 16 | 0 |
| 30 Sep 16 | 562 | 41 | 16 | 0 |
| 30 Jun 16 | 553 | 36 | 16 | 0 |
| 31 Mar 16 | 556 | 27 | 16 | 0 |
| 31 Dec 15 | 553 | 38 | 16 | 0 |
| 30 Sep 15 | 548 | 34 | 15 | 0 |
| 30 Jun 15 | 547 | 40 | 15 | 0 |
| 31 Mar 15 | 535 | 42 | 15 | 0 |
| 31 Dec 14 | 525 | 26 | 15 | 0 |
| 30 Sep 14 | 511 | 29 | 14 | 0 |
| 30 Jun 14 | 496 | 24 | 14 | 0 |
| 31 Mar 14 | 479 | 18 | 14 | 0 |
| 31 Dec 13 | 470 | 24 | 14 | 0 |
| 30 Sep 13 | 462 | 19 | 14 | 0 |
| 30 Jun 13 | 458 | 20 | 14 | 0 |
Ingresos de calidad: COP tiene ganancias de alta calidad.
Margen de beneficios creciente: Los actuales márgenes de beneficio(3.7%) de COP son inferiores a los del año pasado (6.2%).
Análisis del flujo de caja libre vs. Beneficios
Análisis del crecimiento de los beneficios en el pasado
Tendencia de beneficios: Los beneficios de COP han disminuido en un 4.5% al año en los últimos 5 años.
Acelerando crecimiento: COP ha tenido un crecimiento negativo de los beneficios en el último año, por lo que no puede compararse con su media de 5 años.
Beneficios vs. Industria: COP tuvo un crecimiento negativo de los beneficios (-37.5%) durante el año pasado, lo que dificulta la comparación con la media de la industria Healthcare Services (-36.8%).
Rentabilidad financiera
Alta ROE: La rentabilidad financiera de COP (7%) se considera baja.